JANX
Price
$29.25
Change
-$0.97 (-3.21%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
1.73B
62 days until earnings call
PYXS
Price
$1.04
Change
-$0.03 (-2.80%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
62.14M
8 days until earnings call
Ad is loading...

JANX vs PYXS

Header iconJANX vs PYXS Comparison
Open Charts JANX vs PYXSBanner chart's image
Janux Therapeutics
Price$29.25
Change-$0.97 (-3.21%)
Volume$12.03K
Capitalization1.73B
Pyxis Oncology
Price$1.04
Change-$0.03 (-2.80%)
Volume$17.42K
Capitalization62.14M
JANX vs PYXS Comparison Chart
Loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JANX vs. PYXS commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and PYXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (JANX: $30.19 vs. PYXS: $1.07)
Brand notoriety: JANX and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 82% vs. PYXS: 61%
Market capitalization -- JANX: $1.73B vs. PYXS: $62.14M
JANX [@Biotechnology] is valued at $1.73B. PYXS’s [@Biotechnology] market capitalization is $62.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 5 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • JANX’s TA Score: 5 bullish, 4 bearish.
  • PYXS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than JANX.

Price Growth

JANX (@Biotechnology) experienced а -5.15% price change this week, while PYXS (@Biotechnology) price change was -3.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.64%. For the same industry, the average monthly price growth was -8.11%, and the average quarterly price growth was -7.39%.

Reported Earning Dates

JANX is expected to report earnings on May 13, 2025.

PYXS is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+0.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.73B) has a higher market cap than PYXS($62.1M). PYXS YTD gains are higher at: -31.410 vs. JANX (-43.612). PYXS has higher annual earnings (EBITDA): -64.04M vs. JANX (-83.88M). JANX has more cash in the bank: 658M vs. PYXS (145M). PYXS has less debt than JANX: PYXS (20.5M) vs JANX (23.4M). PYXS has higher revenues than JANX: PYXS (16.1M) vs JANX (13M).
JANXPYXSJANX / PYXS
Capitalization1.73B62.1M2,784%
EBITDA-83.88M-64.04M131%
Gain YTD-43.612-31.410139%
P/E RatioN/AN/A-
Revenue13M16.1M81%
Total Cash658M145M454%
Total Debt23.4M20.5M114%
TECHNICAL ANALYSIS
Technical Analysis
JANXPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 21 days ago
87%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VDSCX17.57N/A
N/A
Victory Diversified Stock C
FLMAX9.21N/A
N/A
Meeder Muirfield Adviser
LGMNX24.71N/A
N/A
Loomis Sayles Global Allocation N
TCIWX24.59N/A
N/A
Nuveen International Eq Idx W
SOIAX8.72N/A
N/A
Spirit of America Real Estate Inc&Gr Ins

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with VKTX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-1.47%
VKTX - JANX
63%
Loosely correlated
-3.92%
DNLI - JANX
46%
Loosely correlated
-10.43%
SKYE - JANX
41%
Loosely correlated
-4.18%
LGND - JANX
39%
Loosely correlated
-4.73%
OCUL - JANX
37%
Loosely correlated
+1.46%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-7.76%
KURA - PYXS
60%
Loosely correlated
-3.85%
CTMX - PYXS
39%
Loosely correlated
+0.72%
ABOS - PYXS
35%
Loosely correlated
-4.00%
SANA - PYXS
33%
Loosely correlated
-2.33%
JANX - PYXS
33%
Loosely correlated
-1.47%
More